Fuller & Thaler Asset Management Inc. Makes New Investment in AdaptHealth Corp. $AHCO

Key Points

• Fuller & Thaler Asset Management Inc. acquired a new stake in AdaptHealth Corp. worth approximately $532,000, purchasing 49,115 shares in the first quarter.
• AdaptHealth's stock is currently down 1.3%, trading at $9.33, with a 12-month range of $7.11 to $11.70, and an average consensus rating of "Buy" among analysts.
• Institutional investors own 82.67% of AdaptHealth's stock, with notable increases in holdings from GAMMA Investing LLC and Brooklyn Investment Group during the first quarter.

Fuller & Thaler Asset Management Inc. acquired a new stake in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 49,115 shares of the company's stock, valued at approximately $532,000.

Other hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC grew its position in AdaptHealth by 175.2% during the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock valued at $81,000 after buying an additional 4,758 shares during the period. Brooklyn Investment Group boosted its stake in AdaptHealth by 531.8% in the first quarter. Brooklyn Investment Group now owns 7,563 shares of the company's stock valued at $82,000 after acquiring an additional 6,366 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new position in shares of AdaptHealth during the 1st quarter valued at approximately $114,000. Guggenheim Capital LLC increased its stake in shares of AdaptHealth by 10.1% during the 4th quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after purchasing an additional 1,525 shares during the last quarter. Finally, Legato Capital Management LLC purchased a new stake in shares of AdaptHealth during the 1st quarter worth approximately $167,000. 82.67% of the stock is currently owned by institutional investors.

AdaptHealth Stock Down 1.3%

AHCO opened at $9.33 on Thursday. AdaptHealth Corp. has a 12 month low of $7.11 and a 12 month high of $11.70. The company has a market cap of $1.26 billion, a PE ratio of 17.28, a price-to-earnings-growth ratio of 1.06 and a beta of 1.58. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.14. The company has a 50 day moving average of $9.19 and a 200 day moving average of $9.26.

Wall Street Analyst Weigh In

AHCO has been the topic of several research analyst reports. Wall Street Zen upgraded AdaptHealth from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Royal Bank Of Canada lowered their target price on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research note on Thursday, May 8th. Finally, Truist Financial dropped their price target on AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, May 12th. Five research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $13.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.